Induction of hepatic peroxisome proliferation by 8-2 telomer alcohol feeding in mice: formation of perfluorooctanoic acid in the liver.

The effects of dietary administration of 1H, 1H, 2H, 2H-perfluorodecanol (8-2 telomer alcohol), on peroxisome proliferation in the liver of mice were studied. Male ddY mice were fed on a diet containing 8-2 telomer alcohol at concentrations of 0, 0.025, 0.05, 0.1, and 0.2% (w/w) for 7, 14, 21, and 28 days. These treatments with 8-2 telomer alcohol caused liver enlargement in a dose- and duration-dependent manner. Peroxisome proliferation in the liver of mice was confirmed by electron microscopic examination. Peroxisomal acyl-CoA oxidase was induced by these treatments with 8-2 telomer alcohol in a dose- and time-dependent manner. The concentration of perfluorooctanoic acid (PFOA) and related compounds were determined in the liver and plasma, since PFOA had been shown to be a possible metabolite of 8-2 telomer alcohol and to cause significant peroxisome proliferation in rodents. Five metabolites, namely, perfluorooctanoic acid (PFOA), perfluorononanoic acid (PFNA), 2H, 2H-perfluorodecanoic acid (8-2 telomer acid), and two unidentified metabolites, were present in the liver and serum. PFOA was confirmed to be accumulated in the liver of mice following the administration of 8-2 telomer alcohol in a dose- and duration-dependent manner. A linear relationship was observed between the concentration of PFOA and the activity of peroxisomal acyl-CoA oxidase in the liver of mice. These results strongly suggest that PFOA, but not 8-2 telomer alcohol itself, caused peroxisome proliferation in the liver. The present study provided evidence that 8-2 telomer alcohol is converted into PFOA in vivo and that the PFOA formed produces biological effects in the liver of mice.

[1]  K. Beier,et al.  Application of automatic image analysis for quantitative morphological studies of peroxisomes in rat liver in conjunction with cytochemical staining with 3‐3′‐diaminobenzidine and immunocytochemistry , 1992, Microscopy research and technique.

[2]  Y. Kawashima,et al.  Characterization of hepatic responses of rat to administration of perfluorooctanoic and perfluorodecanoic acids at low levels. , 1995, Toxicology.

[3]  N. Kudo,et al.  Induction by perfluorinated fatty acids with different carbon chain length of peroxisomal beta-oxidation in the liver of rats. , 2000, Chemico-biological interactions.

[4]  D F Hagen,et al.  Characterization of fluorinated metabolites by a gas chromatographic-helium microwave plasma detector--the biotransformation of 1H, 1H, 2H, 2H-perfluorodecanol to perfluorooctanoate. , 1981, Analytical biochemistry.

[5]  J. V. Vanden Heuvel,et al.  Tissue distribution, metabolism, and elimination of perfluorooctanoic acid in male and female rats. , 1991, Journal of biochemical toxicology.

[6]  J. Depierre,et al.  Perfluorooctanoic acid has persistent effects on peroxisome proliferation and related parameters in mouse liver. , 1992, Journal of biochemical toxicology.

[7]  W. Stott Chemically induced proliferation of peroxisomes: implications for risk assessment. , 1988, Regulatory toxicology and pharmacology : RTP.

[8]  K. Andersson,et al.  Effects of perfluoro fatty acids on peroxisome proliferation and mitochondrial size in mouse liver: dose and time factors and effect of chain length. , 1993, Xenobiotica; the fate of foreign compounds in biological systems.

[9]  R H Ophaug,et al.  Metabolic Handling of Perfluorooctanoic Acid in Rats , 1980, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[10]  Richard E. Peterson,et al.  Dose-related effects of perfluorodecanoic acid on growth, feed intake and hepatic peroxisomal β-oxidation , 2006, Archives of Toxicology.

[11]  P. Lazarow Three hypolipidemic drugs increase hepatic palmitoyl-coenzyme A oxidation in the rat. , 1977, Science.

[12]  Scott A Mabury,et al.  Polyfluorinated telomer alcohols and sulfonamides in the North American troposphere. , 2004, Environmental science & technology.

[13]  Qiang Yang,et al.  Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic acid in mice. , 2001, Biochemical pharmacology.

[14]  Qian Yang,et al.  Involvement of the peroxisome proliferator-activated receptor alpha in the immunomodulation caused by peroxisome proliferators in mice. , 2002, Biochemical pharmacology.

[15]  Craig S. Criddle,et al.  Fluorinated Organics in the Biosphere , 1997 .

[16]  Yoichi Kawashima,et al.  Toxicity and toxicokinetics of perfluorooctanoic acid in humans and animals. , 2003, The Journal of toxicological sciences.

[17]  Y. Kawashima,et al.  Sex-related difference in the inductions by perfluoro-octanoic acid of peroxisomal beta-oxidation, microsomal 1-acylglycerophosphocholine acyltransferase and cytosolic long-chain acyl-CoA hydrolase in rat liver. , 1989, The Biochemical journal.

[18]  John P Giesy,et al.  Perfluorooctanesulfonate and related fluorinated hydrocarbons in mink and river otters from the United States. , 2002, Environmental science & technology.

[19]  Jeffrey H Mandel,et al.  Human donor liver and serum concentrations of perfluorooctanesulfonate and other perfluorochemicals. , 2003, Environmental science & technology.

[20]  M. Connock,et al.  A sensitive spectrophotometric assay for peroxisomal acyl-CoA oxidase. , 1985, The Biochemical journal.

[21]  Scott A Mabury,et al.  Fluorotelomer alcohol biodegradation yields poly- and perfluorinated acids. , 2004, Environmental science & technology.

[22]  M. Rao,et al.  Hepatic Peroxisome Proliferation: An Overview , 1988 .

[23]  Y. Kawashima,et al.  Comparative studies on sex-related difference in biochemical responses of livers to perfluorooctanoic acid between rats and mice. , 1990, Biochemical pharmacology.

[24]  R. Hess,et al.  NATURE OF THE HEPATOMEGALIC EFFECT PRODUCED BY ETHYL-CHLOROPHENOXY-ISOBUTYRATE IN THE RAT , 1965, Nature.

[25]  J. Reddy,et al.  Evaluation of Selected Hypolipidemic Agents for the Induction of Peroxisomal Enzymes and Peroxisome Proliferation in the Rat Liver , 1983, Human toxicology.

[26]  C. Duve,et al.  A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[27]  K. Andersson,et al.  The effects of perfluoro-octanoic acid on hepatic peroxisome proliferation and related parameters show no sex-related differences in mice. , 1992, The Biochemical journal.

[28]  J. S. Eldridge,et al.  Quantitative characterization of trace levels of PFOS and PFOA in the Tennessee River. , 2002, Environmental science & technology.

[29]  N. Kudo,et al.  Determination of perfluorinated carboxylic acids in biological samples by high-performance liquid chromatography. , 1998, Journal of chromatography. B, Biomedical sciences and applications.

[30]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[31]  D. Noonan,et al.  Mechanisms of peroxisome proliferation by perfluorooctanoic acid and endogenous fatty acids. , 1998, General pharmacology.